Inventor
SCHWEIGHOFFER FABIEN
FR15 patents
⚠️ This page may combine multiple inventors who share the name “SCHWEIGHOFFER FABIEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EXONHIT THERAPEUTICS SA
8 patentsUS6881571B1Apr 19, 2005
Qualitative differential screening
EXONHIT THERAPEUTICS SA27 citations91
US6372432B1Apr 16, 2002
Methods and composition for the detection of pathologic events
EXONHIT THERAPEUTICS SA46 citations91
US6251590B1Jun 26, 2001
Differential Qualitative screening
EXONHIT THERAPEUTICS SA39 citations91
US6509153B1Jan 21, 2003
Genetic markers of toxicity preparation and uses
EXONHIT THERAPEUTICS SA8 citations72
US7514432B2Apr 7, 2009
Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
EXONHIT THERAPEUTICS SA6 citations56
US6855736B2Feb 15, 2005
Molecular target of neurotoxicity
EXONHIT THERAPEUTICS SA3 citations52
US8003375B2Aug 23, 2011
Qualitative differential screening
EXONHIT THERAPEUTICS SA0 citations51
US7872015B2Jan 18, 2011
Methods involving PDE4, compositions, and the screening thereof, for the treatment of degenerative ocular pathologies
EXONHIT THERAPEUTICS SA0 citations42
RHONE POULENC RORER SA
4 patentsUS5656595AAug 12, 1997
Peptides having GDP exchange factor activity, nucleic acid sequences coding for these peptides, preparation and use
RHONE POULENC RORER SA24 citations92
US5886150AMar 23, 1999
Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof
RHONE POULENC RORER SA41 citations90
US5831048ANov 3, 1998
Grb3-3 cDNA and polypeptides
RHONE POULENC RORER SA15 citations81
US6180362B1Jan 30, 2001
Peptides which inhibit ras protein activity, their preparation and use
RHONE POULENC RORER SA7 citations72
AVENTIS PHARMA SA
3 patentsUS6544948B1Apr 8, 2003
ΔP62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
AVENTIS PHARMA SA9 citations73
US6159947ADec 12, 2000
Anti-RAS intracellular binding proteins and use thereof
AVENTIS PHARMA SA14 citations73
USRE37952EDec 31, 2002
Grb3-3 cDNA and polypeptides
AVENTIS PHARMA SA0 citations51